Journals / E Journal of Cardiovascular Medicine / 2021 / Cilt: 9 - Sayı: 3

Endovascular Treatment of Subclavian Artery Stenosis: Single-Center Experience

Pages
136–142
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: In conclusion, signs and symptoms can be managed effectively with endovascular techniques in patients with significant subclavian artery disease.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: The etiology of subclavian artery stenosis can be very different, but typically the most common form is due to atherosclerotic disease.
📊
Key Findings & Data:Endovascular stenting is preferred over surgery because of its high success rate, less invasive nature, and minimal complication rate.
💡
Conclusion & Impact:Conclusion: In conclusion, signs and symptoms can be managed effectively with endovascular techniques in patients with significant subclavian artery disease.
🔬Design:Research Article
📍Scope:2019 Verileri
⚙️Variables:Domain Parameters

Özet

Objectives: The etiology of subclavian artery stenosis can be very different, but typically the most common form is due to atherosclerotic disease. Interventional treatment is generally indicated for upper limb ischemia, vertebrobasilar symptoms, subclavian steal syndrome, and coronary steal syndrome. Endovascular stenting is preferred over surgery because of its high success rate, less invasive nature, and minimal complication rate. In this study, the characteristics of patients treated endovascularly due to subclavian artery stenosis in our center and their procedural details will be examined. Materials and Methods: We retrospectively analyzed patients with subclavian artery stenosis treated by endovascular techniques in our center between January 2019 and January 2021. Results: Twelve (80%) of 15 patients with stenotic subclavian arteries were successfully treated with endovascular techniques. In 3 patients, the procedure was terminated with failure. The mean age of the patients was 64.66 years and 3 (20%) of the patients were female. All of the patients were receiving antihypertensive treatment with the diagnosis of hypertension, and 4 (26.66%) patients had diabetes mellitus, 13 (86.66%) patients had hyperlipidemia, and 13 (86.66%) patients had coronary artery disease. In 2 patients, the lesion was diagnosed in the right subclavian artery. In 7 patients, the procedure was performed with the telescopic method from a transfemoral approach. In 5 patients, the transradial approach was used. In 3 patients, the procedure was performed directly over the transbrachial approach.Balloon expandable stent implantation was performed in 10 (66.66%) patients at the end of the procedure, and selfexpandable stent implantation was performed in 1 patient. Conclusion: In conclusion, signs and symptoms can be managed effectively with endovascular techniques in patients with significant subclavian artery disease. In this study, we shared our real-life data on subclavian artery endovascular treatment.

🔖

Cite This Article

ASIL, S., EŞKİ, S., GENEŞ, M., GÖRMEL, S., YAŞAR, S., FIRTINA, S., TOLUNAY, H., YÜKSEL, U. Ç., ÇELİK, M. (2021). Endovascular Treatment of Subclavian Artery Stenosis: Single-Center Experience. E Journal of Cardiovascular Medicine, Cilt: 9 - Sayı: 3, 136–142. https://ajindex.com/articles/408941

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Shadman R, Criqui MH, Bundens WP, et al. Subclavian artery stenosis: prevalence, risk factors, and association with cardiovascular diseases. J Am Coll Cardiol 2004;44:618-23
  2. Ochoa VM, Yeghiazarians Y. Subclavian artery stenosis: a review for the vascular medicine practitioner. Vasc Med 2011;16:29-34
  3. Rodriguez-Lopez JA, Werner A, Martinez R, Torruella LJ, Ray LI, Diethrich EB. Stenting for atherosclerotic occlusive disease of the subclavian artery. Ann Vasc Surg 1999;13:254-60
  4. Bachman DM, Kim RM. Transluminal dilatation for subclavian steal syndrome. AJR Am J Roentgenol 1980;135:995-6
  5. Aboyans V, Ricco JB, Bartelink MEL, et al. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: the European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur Heart J 2018;39:763-816
  6. Patel SN, White CJ, Collins TJ, et al. Catheter-based treatment of the subclavian and innominate arteries. Catheter Cardiovasc Interv 2008;71:963-8
  7. Aydın C, Ay Y, Kara İ, et al. Subklavyen Arter Tıkanıklığında Cerrahi Revaskülarizasyon Uygulamalarımızın Erken-Orta Dönem Sonuçları. Koşuyolu Kalp Dergisi 2013;16:19-24
  8. Chatterjee S, Nerella N, Chakravarty S, Shani J. Angioplasty alone versus angioplasty and stenting for subclavian artery stenosis--a systematic review and meta-analysis. Am J Ther 2013;20:520-3
  9. De Vries JP, Jager LC, Van den Berg JC, et al. Durability of percutaneous transluminal angioplasty for obstructive lesions of proximal subclavian artery: long-term results. J Vasc Surg 2005;41:19-23
  10. AbuRahma AF, Bates MC, Stone PA, et al. Angioplasty and stenting versus carotid-subclavian bypass for the treatment of isolated subclavian artery disease. J Endovasc Ther 2007;14:698-704
  11. Heuser RR, Henry M. Textbook of peripheral vascular interventions: Taylor & Francis US; 2008.